About
Dr Henno Martin is a Consultant Clinical Oncologist at Cambridge University Hospitals and GenesisCare Newmarket, specialising in the treatment of prostate, bladder and breast cancers across all stages of disease. He provides both systemic anti-cancer therapies and radiotherapy, including brachytherapy, and also works closely with Sciensus Homecare to enable patients to receive treatment safely and effectively in their own homes.
Alongside cancer treatment, Dr Martin places a strong emphasis on supportive care and quality of life. He has authored several Cambridge University Hospitals guidelines on the management of cancer treatment side effects and has completed specialist European Society for Medical Oncology (ESMO) training in supportive care, ensuring patients are well supported during and after treatment.
His research interests focus on the development of simple blood-based tests, including circulating tumour DNA, to guide cancer care and reduce the need for invasive monitoring. This work has been recognised through national awards, competitive research funding and presentations at international conferences.
Dr Martin contributes at a national level through his work with the Royal College of Radiologists and as a case reviewer for the National Confidential Enquiry into Patient Outcomes and Death. He is also deeply committed to education and mentorship, having received multiple commendations for his teaching of medical students at the University of Cambridge.
He trained in medicine at the Universities of Oxford and Cambridge, with further academic study in Göttingen and Freiburg.
https://shelfordoncology.org/
Alongside cancer treatment, Dr Martin places a strong emphasis on supportive care and quality of life. He has authored several Cambridge University Hospitals guidelines on the management of cancer treatment side effects and has completed specialist European Society for Medical Oncology (ESMO) training in supportive care, ensuring patients are well supported during and after treatment.
His research interests focus on the development of simple blood-based tests, including circulating tumour DNA, to guide cancer care and reduce the need for invasive monitoring. This work has been recognised through national awards, competitive research funding and presentations at international conferences.
Dr Martin contributes at a national level through his work with the Royal College of Radiologists and as a case reviewer for the National Confidential Enquiry into Patient Outcomes and Death. He is also deeply committed to education and mentorship, having received multiple commendations for his teaching of medical students at the University of Cambridge.
He trained in medicine at the Universities of Oxford and Cambridge, with further academic study in Göttingen and Freiburg.
https://shelfordoncology.org/
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Henno Martin
Education & training
-
2012–2018 MD · Medicine and Surgery
-
2018–2022 Residency · Oncology
-
2022–2023 Fellowship · Subspecialty training
Career & appointments
-
2022-09–2023-08 Junior consultant
Licenses & insurance
Medical licenses
GB — Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
Allianz Professional · 3,000,000 EUR coverage · No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 412 |
| Annual physical exam | 99395 | 1,690 |
| Vaccination administration | 90471 | 994 |
| Minor procedure (skin) | 17110 | 1,365 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 120 min | in_clinic | 720.00 EUR |
| Minor procedure (skin) | 30 min | in_clinic | 630.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 21 · i10: 12
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.5784/euroclin.2025.0 · PMID: 36772841 · cited by 148
-
European registry analysis of Oncology outcomes
DOI: 10.8111/euroclin.2024.1 · PMID: 32390022 · cited by 198
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.8710/euroclin.2023.2 · PMID: 39873804 · cited by 112
-
European registry analysis of Oncology outcomes
DOI: 10.3845/euroclin.2022.3 · PMID: 33708635 · cited by 146
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · Cambridge · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — Cambridge · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
- 🏆 Young Investigator Award · European Society · 2023 · international
Society memberships
- WONCA Europe — Family Doctors — Member · Since 2023
- national college of family doctors — Member · Since 2023
- European Union of Medical Specialists (UEMS) — Member · Since 2023
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · henno.martin@euroclinics.example
- Accepted international insurance
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
Location
1 tagPatient reviews
18 verified reviews5.00
★★★★★
18 reviews
- Bedside Manner
- 5.0
- Knowledge
- 5.0
- Wait Time
- 4.8
- Staff Friendliness
- 5.0
- Ease Of Appointment
- 4.9
- Value For Money
- 4.9
- Would Recommend Pct
- 99.0
Share your experience — help other patients find the right doctor. Write a review →
Recent reviews
-
★★★★★ ✓ Verified Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verified Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verified Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
